Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing

Key Points

• The aim is to explore the adoption of whole genome sequencing (WGS) and transcriptome sequencing (WTS) as routine healthcare practices for cancer patients.
• Reviewing cost structures of WGS/WTS tests
• Analyzing the current pricing of consumables
• Assessing clinical implementation processes
• Lower costs of consumables are likely to improve adoption rates of WGS/WTS
• WGS/WTS can be integrated into clinical settings more feasibly
• Potential enhancement of personalized cancer treatment options

Abstract